Aneel K. Sandhu
FDA investigator
Appears on 2 documents from 2006 to 2016, mostly at sites in California. Most often cites circumstances in which IRB review is required (21 CFR 56.103).
- 2
- Documents on file
- 1.0
- Observations per 483
- 2006
- First seen
- 2016
- Most recent
What they cite most
From 1 observations- 21 CFR 56.103Circumstances in which IRB review is required1
Activity by year
2006: 1, 2016: 1
Where
California 1 · Nevada 1
Often inspects with
Is Aneel K. Sandhu coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2016-08-18 | 483 Theranos, Inc.Aug 18, 2016 · Palo Alto, California | Palo Alto, California | 1 | |
| 2006-09-14 | EIR CellFreeze, Inc.Sep 14, 2006 · Las Vegas, Nevada | Las Vegas, Nevada | — |
About this profile
What does Aneel K. Sandhu inspect?
Aneel K. Sandhu appears on 2 documents on file covering 2 sites, mostly in California.
What do they cite most often?
21 CFR 56.103 (circumstances in which IRB review is required).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Aneel K. Sandhu is dated Aug 18, 2016.